Histopathological UIP as a Prognostic Biomarker in Fibrotic Interstitial Lung Diseases with Preserved Lung Function. - Amsterdam 2025

Predicting progression in pulmonary fibrosis: biomarkers and beyond

Chair(s): Diana Calaras, Iftikhar Nadeem

Session type: Poster session

Histopathological UIP as a Prognostic Biomarker in Fibrotic Interstitial Lung Diseases with Preserved Lung Function.

Silvia Carlini

EVENTS HOME

Poster
Abstract

Previous presentation

Next presentation

Session content

Multiprotein predictor of short-term mortality in idiopathic pulmonary fibrosis (IPF)

Jamie L. Todd

Poster

Abstract

Could serum vanin-1 level be a novel biomarker in patients with idiopathic pulmonary fibrosis?

Gözde Öksüzler Kizilbay

Poster

Abstract

Lipid metabolism alterations in idiopathic pulmonary fibrosis: impact on disease severity and prognosis

Giovanni Franco

Poster

Abstract

Histopathological UIP as a Prognostic Biomarker in Fibrotic Interstitial Lung Diseases with Preserved Lung Function.

Silvia Carlini

Poster

Abstract

Fibroblast foci in transbronchial lung cryobiopsy specimens predict progression in interstitial lung diseases

Eeva Saari

Poster

Abstract

MMP-7 and MPO as severity biomarkers in interstitial lung disease(ILD) patients in a brazilian cohort

Julia Rodrigues Ferraz Silva

Poster

Abstract

Tissue turnover biomarkers are associated with lung function and exercise capacity in idiopathic pulmonary fibrosis

Filipa B Simões

Poster

Abstract

NEUTROPHIL GELATINASE-ASSOCIATED LIPOCALIN (NGAL) AS A BIOMARKER OF THE SEVERITY OF IDIOPATHIC PULMONARY FIBROSIS (IPF)

Valeriia Dmytrychenko

Poster

Abstract

MATRIX METALLOPROTEINASES (MMPs) AND SEVERITY OF OVERCOMING IDIOPATHIC PULMONARY FIBROSIS (IPF)

Valeriia Dmytrychenko

Poster

Abstract

The clinical meaning of the Usual Interstitial Pneumonia (UIP) detected by transbronchial lung cryobiopsy (TBLC)

Simone Petrarulo

Poster

Abstract

Bronchoalveolar lavage cell differential count is associated with survival and radiological UIP pattern in familial pulmonary fibrosis

Hanna Jaula

Poster

Abstract

Clinical Characteristics and Whole Exome Sequencing Results from a Prospective Observational Cohort Study of Familial Pulmonary Fibrosis

Aoife Carolan

Poster

Abstract

Exploring the value of electronic nose technology to predict disease progression in pulmonary fibrosis

Bart J. Formsma

Poster

Abstract

Soluble cytokine receptors in idiopathic pulmonary fibrosis

Kiminobu Tanizawa

Poster

Abstract

Mucin1 and Mucin4 as diagnostic biomarkers of Interstitial Lung Disease and its Acute Exacerbation

Motoko Nomura

Poster

Abstract

Biomarkers of epithelial injury and disease progression correlate with cough severity in patients with pulmonary fibrosis

Lutz Wollin

Poster

Abstract

Advancing Pulmonary Fibrosis Care: Integrating Genomic Insights into Clinical Practice

Eva Carmona

Poster

Abstract

Risk score including family history for patients with interstitial lung disease waiting for lung transplantation

Kiminobu Tanizawa

Poster

Abstract

Sublingual assessment of the endothelial glycocalyx reveals vascular endothelial dysfunction in patients with fibrotic interstitial lung disease

Giles Dixon

Poster

Abstract

The Role and Evaluation of the Neutrophil-to-Lymphocyte Ratio in the Differential Diagnosis of IPF and Non-IPF Interstitial Lung Diseases

Ebru Duran

Poster

Abstract

CDN Connection Issue

The ERS Congress 2025, Amsterdam

#{title}